|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 531.9 USD | +0.86% |
|
+0.67% | +14.88% |
| Apr. 22 | Mizuho Securities Raises Price Target on McKesson to $540 From $505, Neutral Rating Kept | MT |
| Apr. 18 | Nephron Research Raises McKesson's Price Target to $600 From $530 | MT |
FRANKFURT (Reuters) - Germany's antitrust regulator raided eight drug wholesale companies, including a subsidiary of U.S. healthcare services provider McKesson Corp, on suspicion of illegal collusion.
A spokesman for Germany's Cartel Office, who confirmed the raids on Thursday, declined to provide the names of the companies targeted.
Germany-based Gehe, a drugs distributor which McKesson controls as part of its 2014 purchase of most of Celesio AG's shares, said in a written statement its offices had been searched and that it was fully cooperating with antitrust authorities, declining to comment further.
(Reporting by Matthias Inverardi; Writing by Ludwig Burger; Editing by Harro ten Wolde)
| 1st Jan change | Capi. | |
|---|---|---|
| +14.88% | 69.91B | |
| +5.62% | 8.32B | |
| +5.20% | 8.07B | |
| -20.43% | 7.97B | |
| +0.85% | 4.56B | |
| +16.98% | 4.31B | |
| -2.00% | 3.99B | |
| -2.54% | 3.87B | |
| +21.87% | 3.63B | |
| +6.45% | 3.3B |
MCKESSON CORPORATION 
